📰 Downstream Processing News
Downstream Processing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Downstream Processing. Real-time updates on events, politics, business and more.
May 29, 2024
Market OverviewThe Global Downstream Processing Market is expected to witness substantial growth over the next decade. Starting from a valuation of USD 36.1 billion in 2023, the market is projected to reach approximately USD 153.8 billion by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 15.6% durin...
May 22, 2024
DBS Asian Insights Conference: Elections Over, Whats the Governments Strategy to Grow the Economy and Achieve Golden Indonesia 2045? | Bahasa Indonesia.21 May 2024.0 min...
April 29, 2024
According to Market.us, the Antibody Production Market Size is anticipated to experience considerable growth, reaching an estimated value of around USD 62.2 billion by the year 2033. This represents a substantial increase from its valuation of USD 18.4 billion in 2023. Over the forecast period from 2024 to 2033, a s...
April 12, 2024
In the fast-paced domain of pharmaceutical contract development and manufacturing organizations (CDMOs), Selkirk Pharma believes it stands out as a beacon of innovation and reliability.
April 8, 2024
Increase in prevalence of chronic diseases, rise in research and development activities, and increase in government initiatives and funding are the major factors which drive the growth of the global antibody production market.Wilmington, New Castle, Delaware , April 08, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Antibody Production Market by Product (Instruments, Consumables), Process (Upstream Processing, Downstream Processing), and End User (Pharmaceutica...
March 25, 2024
This week, the pharma industry will descend on Pennsylvania Convention Center for Reuters Pharma USA, North America’s largest cross-functional pharma gathering.
March 25, 2024
12-month team-up with Ganfeng to examine lithium conversion plant
February 22, 2024
MIP Discovery, a developer of non-biological affinity reagents designed to accelerate the production of cell and gene therapies, has closed a £7 million Series A financing round, led by Mercia Ventures.
February 21, 2024
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The
January 30, 2024
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The